Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Kymera Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
4
| Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 12,000 options to buy
@ $2.08, valued at
$25k
|
|
| 06/02/2023 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.08, valued at
$20.8k
|
|
| 05/22/2023 |
4
| Chadwick Jeremy G (COO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 33,333 shares
@ $0
Granted 200,000 options to buy
@ $29.64, valued at
$5.9M
|
|
| 05/22/2023 |
3
| Chadwick Jeremy G (COO) has filed a Form 3 on Kymera Therapeutics, Inc. |
| 01/13/2023 |
4
| BVF PARTNERS L P/IL (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Bought 10,961 shares
@ $29.8869, valued at
$327.6k
Bought 11,149 shares
@ $29.8869, valued at
$333.2k
Bought 2,985 shares
@ $31.2426, valued at
$93.3k
Bought 15,912 shares
@ $31.2426, valued at
$497.1k
|
|
| 01/13/2023 |
4
| Booth Bruce (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Sold 21,683 shares
@ $29.96, valued at
$649.6k
Sold 6,071 shares
@ $29.96, valued at
$181.9k
Sold 77,128 shares
@ $30.29, valued at
$2.3M
Sold 21,592 shares
@ $30.29, valued at
$654k
|
|
| 01/13/2023 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Sold 21,683 shares
@ $29.96, valued at
$649.6k
Sold 6,071 shares
@ $29.96, valued at
$181.9k
Sold 77,128 shares
@ $30.29, valued at
$2.3M
Sold 21,592 shares
@ $30.29, valued at
$654k
|
|
| 01/04/2023 |
4
| Chiniara Ellen (Chief Legal Officer) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 37,500 shares
@ $0
Granted 225,000 options to buy
@ $24.84, valued at
$5.6M
|
|
| 01/04/2023 |
3
| Chiniara Ellen (Chief Legal Officer) has filed a Form 3 on Kymera Therapeutics, Inc. |
| 12/16/2022 |
4
| Booth Bruce (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Sold 112,819 shares
@ $30.28, valued at
$3.4M
Sold 101,189 shares
@ $31.44, valued at
$3.2M
Sold 54,737 shares
@ $32.33, valued at
$1.8M
Sold 13,997 shares
@ $33.34, valued at
$466.7k
Sold 13,335 shares
@ $34.02, valued at
$453.7k
Sold 31,584 shares
@ $30.28, valued at
$956.4k
Sold 28,329 shares
@ $31.44, valued at
$890.7k
Sold 15,324 shares
@ $32.33, valued at
$495.4k
Sold 3,919 shares
@ $33.34, valued at
$130.7k
Sold 3,733 shares
@ $34.02, valued at
$127k
Sold 2,561 shares
@ $30, valued at
$76.8k
|
|
| 12/16/2022 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Sold 112,819 shares
@ $30.28, valued at
$3.4M
Sold 101,189 shares
@ $31.44, valued at
$3.2M
Sold 54,737 shares
@ $32.33, valued at
$1.8M
Sold 13,997 shares
@ $33.34, valued at
$466.7k
Sold 13,335 shares
@ $34.02, valued at
$453.7k
Sold 31,584 shares
@ $30.28, valued at
$956.4k
Sold 28,329 shares
@ $31.44, valued at
$890.7k
Sold 15,324 shares
@ $32.33, valued at
$495.4k
Sold 3,919 shares
@ $33.34, valued at
$130.7k
Sold 3,733 shares
@ $34.02, valued at
$127k
Sold 2,561 shares
@ $30, valued at
$76.8k
|
|
| 12/08/2022 |
4
| Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.08, valued at
$20.8k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Sandor Victor (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 24,000 options to buy
@ $30.92, valued at
$742.1k
|
|
| 11/03/2022 |
3
| Sandor Victor (Director) has filed a Form 3 on Kymera Therapeutics, Inc. |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Jacobs Bruce N. (CFO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.08, valued at
$20.8k
|
|
| 10/17/2022 |
4
| Mainolfi Nello (CEO) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Exercised 32,056 options to buy
@ $2.08, valued at
$66.7k
Exercised 27,676 options to buy
@ $2.08, valued at
$57.6k
|
|
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|